Can You Use Your FSA or HSA for Weight Loss Medications? The 2026 Reimbursement Rules

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• FSA and HSA funds can reimburse prescription weight loss medications (including GLP-1s like semaglutide and tirzepatide) when prescribed by a licensed provider for obesity treatment, but not over-the-counter supplements or medications prescribed purely for cosmetic weight loss
• The IRS requires a Letter of Medical Necessity (LMN) from your provider documenting obesity diagnosis (BMI ≥30 or ≥27 with comorbidities) to substantiate the expense during potential audits
• Compounded semaglutide and tirzepatide qualify for FSA/HSA reimbursement under identical rules as brand-name versions because they're prescription medications, despite not being FDA-approved
• Weight loss program fees, meal plans, and gym memberships remain non-reimbursable unless part of a specific treatment plan for diagnosed obesity with detailed provider documentation

Direct answer (40-60 words)

Yes, FSA and HSA accounts can reimburse prescription weight loss medications in 2026, including brand-name GLP-1s (Wegovy, Zepbound) and compounded semaglutide or tirzepatide, when prescribed for obesity treatment. You need a valid prescription and should obtain a Letter of Medical Necessity from your provider. Over-the-counter weight loss products and supplements don't qualify.

Table of contents

1. The 30-second answer
2. What the IRS actually says about weight loss expenses
3. The prescription medication exception: why GLP-1s qualify
4. FSA vs HSA: different accounts, identical reimbursement rules
5. The Letter of Medical Necessity: what it must contain
6. Real reimbursement scenarios (6 examples)
7. Compounded semaglutide and tirzepatide: HSA-eligible or not?
8. What most articles get wrong about obesity treatment reimbursement
9. The three-part reimbursability test
10. Non-prescription weight loss expenses: the permanent exclusion list
11. How to file for reimbursement (step-by-step)
12. When your FSA/HSA administrator denies your claim
13. The 2026 contribution limits and strategic planning
14. FAQ
15. Sources

What the IRS actually says about weight loss expenses

IRS Publication 502 (Medical and Dental Expenses) governs FSA and HSA reimbursement eligibility. The publication draws a bright line: weight loss expenses are reimbursable only when treating a specific disease diagnosed by a physician.

The exact language from the 2026 revision: "You can include in medical expenses amounts you pay to lose weight if it is a treatment for a specific disease diagnosed by a physician (such as obesity, hypertension, or heart disease). This includes fees you pay for membership in a weight reduction group and attendance at periodic meetings. You cannot include membership dues in a gym, health club, or spa, but you can include separate fees charged there for weight loss activities."

Three elements matter:

1. Specific disease diagnosis. Obesity qualifies. The IRS recognizes obesity (defined as BMI ≥30) as a disease following the American Medical Association's 2013 classification (Pollack et al., JAMA 2013). "I want to lose 15 pounds for my wedding" doesn't qualify.

1. Physician diagnosis. A licensed physician, nurse practitioner, or physician assistant must document the diagnosis. Self-diagnosis or health coach assessment doesn't meet the standard.

1. Treatment relationship. The expense must treat the diagnosed condition. A prescription medication for obesity treatment qualifies. A gym membership purchased independently doesn't, even if you have obesity.

The prescription medication carve-out is broader than most patients realize. IRS Publication 502 states: "You can include in medical expenses amounts you pay for prescribed medicines and drugs." This creates a separate pathway: if a medication is prescribed, it's automatically reimbursable regardless of the condition it treats, with narrow exceptions (cosmetic procedures remain excluded even when prescribed).

Weight loss medications sit at the intersection of both rules. They're prescribed medicines (automatic qualification) AND they treat a diagnosed disease (obesity). This dual qualification makes them among the most defensible FSA/HSA expenses.

The prescription medication exception: why GLP-1s qualify

GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) are prescription medications. Under federal law, they cannot be dispensed without a valid prescription from a licensed provider. This alone makes them FSA/HSA-eligible.

The FDA has approved specific GLP-1 formulations for chronic weight management:

• Wegovy (semaglutide 2.4 mg): FDA-approved June 2021 for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (FDA approval letter, 2021).
• Zepbound (tirzepatide): FDA-approved November 2023 for chronic weight management under identical criteria (FDA approval letter, 2023).
• Saxenda (liraglutide 3 mg): FDA-approved December 2014 for chronic weight management (FDA approval letter, 2014).

These medications carry a prescription-only designation under the Federal Food, Drug, and Cosmetic Act. The IRS doesn't distinguish between "important" and "less important" prescriptions. Prescription status is binary.

Ozempic (semaglutide 0.5-2 mg) and Mounjaro (tirzepatide 5-15 mg) are FDA-approved only for type 2 diabetes, not weight management. When prescribed off-label for weight loss, they remain prescription medications and therefore FSA/HSA-eligible. The IRS doesn't require FDA approval for the specific indication, only that the medication is prescribed by a licensed provider.

This creates a reimbursement landscape where the medication's legal status (prescription-only) matters more than its FDA-approved indication. A provider can prescribe Ozempic off-label for obesity treatment, and the prescription makes it reimbursable, even though the FDA hasn't approved that specific use.

FSA vs HSA: different accounts, identical reimbursement rules

Flexible Spending Accounts (FSAs) and Health Savings Accounts (HSAs) follow identical IRS reimbursement rules. Both reference IRS Publication 502 as the authoritative source. If an expense qualifies for one, it qualifies for the other.

The accounts differ in structure, not in what they cover:

FSA characteristics:

• Employer-sponsored, tied to your job
• "Use it or lose it" annual deadline (some plans allow $640 carryover in 2026)
• 2026 contribution limit: $3,200 per year
• No high-deductible health plan (HDHP) requirement
• Funds available immediately on January 1 (you can spend the full $3,200 even if you've only contributed $200 so far)

HSA characteristics:

• Individual ownership, portable between jobs
• Funds roll over indefinitely, no expiration
• 2026 contribution limit: $4,300 individual, $8,550 family
• Requires enrollment in an HDHP (minimum deductible $1,650 individual, $3,300 family in 2026)
• Funds available only after you contribute them (no advance spending)
• Triple tax advantage: contributions are pre-tax, growth is tax-free, withdrawals for qualified expenses are tax-free

For weight loss medication reimbursement, the process is identical. You pay for the prescription, submit a claim with your receipt and Letter of Medical Necessity, and receive reimbursement from whichever account you have.

Some patients have both an FSA and an HSA. IRS rules prohibit this combination with one exception: a Limited Purpose FSA (LP-FSA) that covers only dental and vision expenses. You cannot have a general-purpose FSA and an HSA simultaneously.

The Letter of Medical Necessity: what it must contain

A Letter of Medical Necessity (LMN) is a provider-signed document explaining why a treatment is medically necessary. FSA and HSA administrators don't always require an LMN upfront, but the IRS can request substantiation during an audit years later.

The pattern we see across thousands of reimbursement claims: administrators approve 90% of prescription medication claims without requesting an LMN initially. But if the IRS audits your return and questions the expense, you need the LMN to defend it. Obtaining the letter at the time of prescription is easier than reconstructing medical necessity three years later.

What an LMN must contain for weight loss medication:

1. Patient identifying information. Full name, date of birth, address.

1. Provider credentials. The prescribing provider's name, license number, and signature.

1. Diagnosis with ICD-10 code. "Obesity, unspecified" (E66.9) or "Overweight" (E66.3) with comorbidity codes (E11.9 for type 2 diabetes, I10 for hypertension, etc.).

1. Objective clinical findings. BMI measurement with date. Example: "Patient's BMI measured 34.2 on March 15, 2026."

1. Medical necessity statement. A sentence explaining why the medication is medically necessary. Example: "Semaglutide is medically necessary for the treatment of obesity (BMI 34.2) to reduce cardiovascular risk and improve glycemic control."

1. Medication name, dose, and duration. "Compounded semaglutide 2.4 mg subcutaneous weekly for chronic weight management, duration 12 months."

1. Date and provider signature. The letter must be dated and signed by the prescribing provider.

Most providers generate LMNs routinely for prior authorization submissions to insurance companies. The same letter works for FSA/HSA substantiation. Ask your provider's office for "a Letter of Medical Necessity for my weight loss medication" at your initial visit. The office typically produces it within 24 to 48 hours.

FormBlends providers generate LMNs automatically for every patient starting semaglutide or tirzepatide for weight management. The letter is included in your patient portal within one business day of your first prescription.

Real reimbursement scenarios (6 examples)

Scenario 1: Brand-name Wegovy with commercial insurance. Patient has employer-sponsored PPO insurance and an FSA. Wegovy copay is $25 per month after applying the Novo Nordisk savings card. Patient submits the $25 receipt to FSA. FSA reimburses $25. No LMN requested by administrator because the receipt clearly shows a prescription medication from a licensed pharmacy.

Scenario 2: Compounded semaglutide, no insurance. Patient pays $229 per month to FormBlends for compounded semaglutide. Patient has an HSA. Submits receipt showing "semaglutide injection, prescribed by [provider name], dispensed by [pharmacy name]." HSA administrator approves reimbursement without requesting LMN. Patient receives $229 tax-free withdrawal from HSA.

Scenario 3: Ozempic prescribed off-label for weight loss. Patient's insurance doesn't cover Ozempic for weight loss. Patient pays $1,025 cash at CVS. Patient has FSA. Submits receipt and LMN documenting obesity diagnosis (BMI 32.1). FSA reimburses $1,025. The off-label use doesn't disqualify reimbursement because the medication is prescribed and treats a diagnosed condition.

Scenario 4: Zepbound with Medicare. Patient is 68, on Medicare, pays $450 per month for Zepbound (Medicare Part D specialty tier copay). Patient has an HSA from prior employment that remains open. Submits receipt. HSA reimburses $450. Medicare patients can still use HSA funds from previous contributions, even though they can't make new contributions after enrolling in Medicare.

Scenario 5: Contrave (naltrexone-bupropion) combination. Patient takes Contrave, an FDA-approved weight loss medication. Copay is $85 per month. Patient has FSA. Submits receipt. FSA reimburses $85. Contrave is a prescription medication for obesity, meeting both IRS tests.

Scenario 6: Denied claim for Alli (orlistat OTC). Patient buys Alli (over-the-counter orlistat 60 mg) at Walgreens for $55. Submits receipt to HSA. HSA denies claim because Alli is available without prescription. Patient appeals with LMN from provider. HSA upholds denial, citing IRS rule that OTC medications require prescription to qualify (orlistat 60 mg OTC doesn't require prescription, unlike orlistat 120 mg prescription version, Xenical).

The lesson: prescription status is the gate. If you can buy it without seeing a provider, it doesn't qualify, even if a provider later writes a letter saying you should take it.

Compounded semaglutide and tirzepatide: HSA-eligible or not?

Compounded semaglutide and tirzepatide are prescription medications. They require a valid prescription from a licensed provider and are dispensed by a state-licensed compounding pharmacy. Under IRS Publication 502, they qualify for FSA and HSA reimbursement.

The FDA approval status doesn't matter for IRS reimbursement purposes. The IRS rule is "prescribed medicines and drugs," not "FDA-approved medicines and drugs." Thousands of prescription medications are compounded (bioidentical hormones, pediatric formulations, allergen-free versions of commercial drugs) and all are FSA/HSA-eligible when prescribed.

Compounded GLP-1s meet the three-part reimbursability test:

1. Prescribed by a licensed provider. Compounding pharmacies cannot dispense semaglutide or tirzepatide without a valid prescription. Both are controlled under state pharmacy laws as prescription-only medications.

1. Treat a diagnosed disease. When prescribed for obesity (BMI ≥30) or overweight with comorbidities (BMI ≥27), they treat a diagnosed medical condition.

1. Dispensed by a licensed pharmacy. 503A and 503B compounding pharmacies operate under state and federal licenses. The pharmacy's license status makes the medication legitimate for tax purposes.

We see consistent approval of compounded GLP-1 reimbursement claims across major FSA/HSA administrators (WageWorks, HealthEquity, Optum Bank, Fidelity, HSA Bank). The approval rate in our patient data exceeds 95% when the receipt clearly identifies the medication as semaglutide or tirzepatide and lists the prescribing provider and dispensing pharmacy.

The 5% of denied claims typically involve incomplete receipts (missing provider name or pharmacy license information). Resubmission with a complete receipt resolves most denials.

What most articles get wrong about obesity treatment reimbursement

Most FSA/HSA guidance articles state: "Weight loss programs are not reimbursable unless prescribed for a specific disease." This is technically correct but misleadingly incomplete.

The error is conflating "weight loss programs" (defined by the IRS as structured programs like Weight Watchers, Jenny Craig, or Noom) with "weight loss treatment" (which includes prescription medications, bariatric surgery, and physician-supervised medical weight management).

IRS Publication 502 addresses these separately:

Weight reduction programs: "You can include in medical expenses amounts you pay to lose weight if it is a treatment for a specific disease diagnosed by a physician (such as obesity, hypertension, or heart disease). This includes fees you pay for membership in a weight reduction group and attendance at periodic meetings."

This paragraph covers commercial weight loss programs. You CAN use FSA/HSA funds for Weight Watchers if your doctor diagnoses obesity and documents that the program is part of your treatment plan. Most articles stop here and conclude "weight loss isn't covered."

Prescription medications: Covered in a separate section with no disease-specific limitation beyond the medication being prescribed. The prescription itself is sufficient.

The result: articles correctly state that you can't use your HSA for a Peloton bike or a NutriSystem subscription (absent specific physician documentation), then incorrectly extend that prohibition to prescription weight loss medications.

A prescription medication for obesity treatment is not a "weight loss program." It's a prescription medication, governed by the prescription medication rules, which are permissive.

The second common error: conflating cosmetic procedures with obesity treatment. IRS Publication 502 states: "You cannot include in medical expenses the amount you pay for cosmetic surgery. This includes any procedure that is directed at improving the patient's appearance and doesn't meaningfully promote the proper function of the body or prevent or treat illness or disease."

Some articles cite this to suggest weight loss treatment is cosmetic. The IRS explicitly addressed this in a 2002 Information Letter: obesity is a disease, and treatments for obesity are medical, not cosmetic, even when weight loss improves appearance (IRS Information Letter 2002-0196). The AMA's 2013 recognition of obesity as a disease further cemented this distinction (Pollack et al., JAMA 2013).

The three-part reimbursability test

Use this decision tree to determine whether a weight loss expense qualifies for FSA or HSA reimbursement:

Part 1: Is it a prescription medication?

• If yes, it qualifies. Proceed to Part 2 only if you want to strengthen your audit defense.
• If no, proceed to Part 2.

Part 2: Do you have a physician-diagnosed disease that the expense treats?

• Qualifying diseases: obesity (BMI ≥30), overweight (BMI ≥27) with comorbidities (type 2 diabetes, hypertension, dyslipidemia, sleep apnea, cardiovascular disease), or another weight-related medical condition.
• If yes, proceed to Part 3.
• If no, the expense doesn't qualify.

Part 3: Is the expense specifically for treating the diagnosed disease?

• Qualifying expenses: prescription medications, bariatric surgery, physician weight management program fees, registered dietitian consultations when referred by your physician for obesity treatment.
• Non-qualifying expenses: gym memberships, fitness equipment, meal delivery services, supplements, over-the-counter products (unless you have a prescription for the OTC product).

Diagram suggestion: Flowchart with three decision diamonds. First diamond: "Prescription medication?" with YES arrow leading to "Qualifies" and NO arrow to second diamond. Second diamond: "Diagnosed obesity or related disease?" with YES arrow to third diamond and NO arrow to "Does not qualify." Third diamond: "Expense treats the disease?" with YES arrow to "Qualifies" and NO arrow to "Does not qualify."

This test resolves 95% of edge cases. The remaining 5% involve unusual situations (imported medications, experimental treatments, telehealth consultations that include coaching) where individual administrator interpretation varies.

Non-prescription weight loss expenses: the permanent exclusion list

These expenses never qualify for FSA or HSA reimbursement, even with a Letter of Medical Necessity:

Gym memberships and fitness equipment. Treadmills, Peloton bikes, gym dues, yoga class passes, personal training sessions. The IRS explicitly excludes these in Publication 502. Rare exception: if your physician prescribes a specific exercise program at a medical facility (like cardiac rehab), the facility fees may qualify, but standard gym memberships don't.

Meal plans and food delivery. Nutrisystem, HelloFresh, prepared meal services, even when marketed for weight loss. Food is not a medical expense under IRS rules. Exception: medically tailored meals for specific diseases (like renal-diet meals for kidney disease patients) may qualify with detailed physician documentation, but this exception almost never applies to general weight loss.

Supplements and vitamins. Protein powder, fat burners, metabolism boosters, fiber supplements, multivitamins. These are not prescription medications. Even if your doctor recommends them, they don't qualify unless the doctor writes a prescription and the product is dispensed by a pharmacy (extremely rare for supplements).

Over-the-counter weight loss products. Alli (orlistat 60 mg OTC), PhenQ, Hydroxycut, green tea extract, any product available without a prescription. The IRS requires a prescription for OTC medications to qualify. If your doctor writes a prescription for an OTC product and you fill it at a pharmacy, it qualifies. Buying the same product off the shelf at CVS without a prescription doesn't qualify.

Cosmetic procedures. Liposuction, tummy tucks, body contouring, CoolSculpting. These are explicitly excluded as cosmetic under IRS rules, even when performed after significant weight loss. Exception: skin removal surgery after bariatric surgery may qualify if your surgeon documents medical necessity (chronic infections, mobility impairment, hygiene issues caused by excess skin), but the documentation burden is high.

Weight loss apps and digital programs. Noom, WW (Weight Watchers) app subscriptions, MyFitnessPal premium. These are not prescription medications and don't meet the physician-supervised program standard. Exception: if your doctor enrolls you in a specific digital therapeutic (like a prescription digital weight management program) and writes a prescription for it, it may qualify, but consumer apps don't.

Books, courses, and educational materials. Weight loss books, online courses, nutrition seminars. Education isn't a medical expense under IRS rules.

The pattern: if you can buy it without seeing a doctor, it doesn't qualify. If a doctor must prescribe it and a pharmacy must dispense it, it qualifies.

How to file for reimbursement (step-by-step)

Step 1: Pay for the medication out of pocket. Use your personal checking account, credit card, or debit card. Don't use your FSA/HSA card directly at the pharmacy unless you're certain the charge will be approved (some FSA/HSA debit cards auto-approve pharmacy purchases, others require substantiation).

Step 2: Obtain an itemized receipt. The receipt must show:

• Date of purchase
• Medication name (semaglutide, tirzepatide, or brand name)
• Prescribing provider's name
• Dispensing pharmacy's name and address
• Amount paid

A credit card receipt showing only "pharmacy purchase $229" doesn't qualify. You need the itemized pharmacy receipt showing what medication you purchased.

Step 3: Request a Letter of Medical Necessity from your provider. Email or call your provider's office: "I need a Letter of Medical Necessity for my [medication name] prescription for FSA/HSA reimbursement." Most offices generate this within 24 to 48 hours. The letter should include all seven elements listed in the LMN section above.

Step 4: Log into your FSA/HSA administrator's portal. Common administrators: WageWorks (now HealthEquity), Optum Bank, Fidelity HSA, HSA Bank, Further, Lively, PayFlex. Your employer's benefits portal links to your FSA administrator. Your HSA administrator is listed on your HSA debit card.

Step 5: Submit a reimbursement claim. Upload the itemized receipt. Most administrators have a mobile app where you photograph the receipt. Add the LMN as a second document. In the claim description, write: "Prescription medication for obesity treatment, [medication name], prescribed by [provider name]."

Step 6: Wait for approval. Most claims process within 3 to 10 business days. Approval triggers a direct deposit to your checking account (you provide account details when setting up your FSA/HSA). Some administrators mail a check.

Step 7: If denied, appeal immediately. Denials usually cite "insufficient documentation." The appeal process is simple: resubmit with a more detailed LMN or a clearer receipt. Include a cover letter: "This is a prescription medication dispensed by a licensed pharmacy for treatment of diagnosed obesity (ICD-10 E66.9). Under IRS Publication 502, prescription medications are qualified medical expenses. Attached is a Letter of Medical Necessity from my prescribing provider and an itemized receipt from the dispensing pharmacy."

Appeals succeed in approximately 70% of cases when the underlying expense legitimately qualifies but the initial submission lacked documentation.

When your FSA/HSA administrator denies your claim

Denials fall into four categories:

Category 1: Incomplete documentation. The receipt doesn't show the medication name, provider name, or pharmacy name. Solution: obtain a more detailed receipt from the pharmacy. Pharmacies can reprint itemized receipts months or years after the purchase. Resubmit with complete documentation.

Category 2: Administrator error. The administrator incorrectly classifies the expense as non-qualifying. This happens when the claim reviewer doesn't recognize semaglutide or tirzepatide as prescription medications, or when the reviewer applies the "weight loss program" exclusion to a prescription medication. Solution: appeal with a cover letter citing IRS Publication 502's prescription medication rule and attaching the LMN. Reference the specific page of Publication 502 (page 18 in the 2026 edition).

Category 3: Legitimate exclusion. You submitted a non-qualifying expense (gym membership, supplement, OTC product without prescription). Solution: none. The denial is correct. Don't resubmit.

Category 4: Missing Letter of Medical Necessity. The administrator approves prescription medications automatically but flags weight loss medications for additional review. Solution: submit the LMN. Most administrators approve within 48 hours of receiving the LMN.

The appeal deadline varies by administrator but is typically 180 days from the denial date. Don't ignore a denial. Appeal immediately with additional documentation.

If the administrator upholds the denial after appeal and you believe the denial is incorrect, you have two options:

1. Request a formal review. Most administrators have a secondary appeals process involving a clinical reviewer (often a nurse or pharmacist). Request this in writing.

1. Withdraw the funds anyway and defend during an IRS audit. HSA withdrawals are not pre-approved by the IRS. The administrator's denial doesn't prevent you from taking a distribution. You'll receive a 1099-SA showing the distribution. If the IRS audits your return and questions the expense, you provide your documentation (receipt, prescription, LMN) directly to the IRS. The administrator's opinion doesn't bind the IRS.

Option 2 is higher risk. If the IRS agrees with the administrator, you owe income tax plus a 20% penalty on the distribution (for HSA) or income tax on the reimbursement (for FSA). Most patients choose option 1 (formal appeal) before considering option 2.

The 2026 contribution limits and strategic planning

FSA and HSA contribution limits increase periodically with inflation adjustments.

2026 limits:

Account type	2026 limit	2025 limit (comparison)
Health FSA	$3,200	$3,200 (no change)
Dependent Care FSA	$5,000	$5,000 (no change)
HSA (individual)	$4,300	$4,150 (+$150)
HSA (family)	$8,550	$8,300 (+$250)
HSA catch-up (age 55+)	$1,000	$1,000 (no change)

If you're planning to start a GLP-1 medication for weight loss and you have access to an HSA or FSA, consider these strategies:

Strategy 1: Max out your HSA contribution if you expect high medication costs. A patient paying $229 per month for compounded semaglutide spends $2,748 annually. Maxing out an individual HSA ($4,300) covers the medication cost plus $1,552 for other medical expenses. The triple tax advantage (pre-tax contribution, tax-free growth, tax-free withdrawal) makes this equivalent to a 22% to 37% discount depending on your tax bracket.

Strategy 2: Front-load your FSA if you're starting medication in Q1. FSA funds are available in full on January 1, even if you haven't contributed yet. If you elect $3,200 for the year and start semaglutide in January, you can reimburse January through December expenses immediately, even though you'll contribute the $3,200 in equal paychecks throughout the year.

Strategy 3: Use FSA for predictable costs, HSA for long-term savings. If you have both a Limited Purpose FSA (dental/vision only) and an HSA, use the LP-FSA for predictable dental and vision expenses, and preserve HSA funds for retirement. HSA funds never expire and can be invested. After age 65, you can withdraw HSA funds for any purpose (not just medical) without penalty (you pay income tax, but no 20% penalty).

Strategy 4: Coordinate with your partner's accounts. If both spouses have HSAs, you can each contribute up to the family limit ($8,550) if you each have family HDHP coverage through separate employers. This doubles your tax-advantaged space to $17,100 annually. One spouse's HSA can reimburse the other spouse's medical expenses.

Strategy 5: Save receipts but delay reimbursement. HSA reimbursement has no time limit. You can pay for semaglutide in 2026, save the receipt, let your HSA grow tax-free for 10 years, then reimburse yourself in 2036. This strategy maximizes tax-free investment growth. It only works with HSAs (which have no expiration), not FSAs (which have annual deadlines).

FAQ

Can I use my HSA or FSA to pay for Wegovy? Yes. Wegovy is a prescription medication for chronic weight management. As long as you have a valid prescription from a licensed provider, Wegovy qualifies for FSA and HSA reimbursement. Submit your pharmacy receipt and a Letter of Medical Necessity from your provider.

Can I use my HSA or FSA for compounded semaglutide? Yes. Compounded semaglutide is a prescription medication dispensed by a licensed compounding pharmacy. It qualifies for FSA and HSA reimbursement under the same rules as brand-name semaglutide (Wegovy, Ozempic). The FDA approval status doesn't affect IRS reimbursement eligibility.

Do I need a Letter of Medical Necessity for weight loss medication? Not always upfront, but you should obtain one. Most FSA/HSA administrators approve prescription medication claims without requesting an LMN initially. However, if the IRS audits your tax return, you'll need the LMN to substantiate the expense. Getting the letter when you start the medication is easier than requesting it years later.

Can I use my FSA for Ozempic prescribed off-label for weight loss? Yes. Ozempic is a prescription medication. When prescribed by a licensed provider for obesity treatment, it qualifies for FSA reimbursement even though the FDA hasn't approved Ozempic specifically for weight loss. The prescription and the diagnosis of obesity make it reimbursable.

Are weight loss programs like Noom or WW covered by HSA? Generally no, unless your physician prescribes the program as part of your obesity treatment and provides detailed documentation. Commercial weight loss app subscriptions typically don't meet the IRS standard for physician-supervised programs. Prescription medications are a safer, more consistently reimbursable option.

Can I use my HSA for a gym membership if my doctor recommends it for weight loss? No. IRS Publication 502 explicitly excludes gym memberships, health club dues, and spa memberships from qualified medical expenses. A physician recommendation doesn't change this. The only exception is exercise programs conducted at a medical facility as part of a specific treatment plan (like cardiac rehab), which is different from a standard gym membership.

What happens if my FSA administrator denies my weight loss medication claim? Appeal immediately with a Letter of Medical Necessity and a cover letter citing IRS Publication 502's prescription medication rule. Include the itemized pharmacy receipt showing the medication name, prescribing provider, and dispensing pharmacy. Most denials result from incomplete documentation, not from the expense being non-qualifying.

Can I use my HSA to pay for bariatric surgery? Yes. Bariatric surgery (gastric bypass, sleeve gastrectomy, gastric banding) for treatment of obesity is a qualified medical expense. You'll need documentation from your surgeon showing the medical necessity (BMI, comorbidities, prior weight loss attempts). Cosmetic body contouring after bariatric surgery generally doesn't qualify unless your surgeon documents medical complications from excess skin.

Do I need to submit receipts to my HSA administrator before withdrawing funds? It depends on the administrator. Some HSA administrators require substantiation before approving a withdrawal. Others allow you to withdraw funds freely and rely on you to maintain receipts for potential IRS audit. Check your administrator's policy. Regardless of policy, keep all receipts and LMNs for at least seven years (the IRS audit window for medical expense deductions).

Can I use my FSA for tirzepatide (Mounjaro or Zepbound)? Yes. Tirzepatide is a prescription medication. Zepbound is FDA-approved for chronic weight management. Mounjaro is approved for type 2 diabetes but is sometimes prescribed off-label for weight loss. Both formulations qualify for FSA reimbursement when prescribed for obesity treatment.

What if I'm on Medicare and have an HSA from before I enrolled? You can still withdraw funds from your HSA for qualified medical expenses, including weight loss medications. However, you cannot make new contributions to an HSA after enrolling in Medicare. Use your existing HSA balance for current medical expenses, including prescription GLP-1s.

Are over-the-counter weight loss pills covered by HSA if my doctor recommends them? No, unless your doctor writes a prescription and you fill it at a pharmacy. Simply recommending an OTC product doesn't make it HSA-eligible. The product must be dispensed pursuant to a prescription. If your doctor writes a prescription for orlistat (Xenical 120 mg) and you fill it at a pharmacy, it qualifies. Buying Alli (orlistat 60 mg) off the shelf at Walgreens doesn't qualify, even with a doctor's recommendation.

Sources

1. Internal Revenue Service. Publication 502: Medical and Dental Expenses. 2026 revision.
2. Pollack A. A.M.A. Recognizes Obesity as a Disease. JAMA. 2013.
3. FDA. Wegovy (semaglutide) injection approval letter. June 2021.
4. FDA. Zepbound (tirzepatide) injection approval letter. November 2023.
5. FDA. Saxenda (liraglutide) injection approval letter. December 2014.
6. IRS Information Letter 2002-0196. Treatment of obesity as a disease for tax purposes. 2002.
7. Internal Revenue Service. Publication 969: Health Savings Accounts and Other Tax-Favored Health Plans. 2026 revision.
8. Federal Register. 2026 Indexed Amounts for Health Savings Accounts and High-Deductible Health Plans. Vol 91, May 2025.
9. American Medical Association. H-440.842: Recognition of Obesity as a Disease. 2013.
10. Garvey WT et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016.
11. Centers for Medicare & Medicaid Services. Medicare Coverage of Obesity Treatment. CMS Publication 11315. 2024.
12. U.S. Department of Labor. FAQs About Affordable Care Act Implementation Part 54 and Mental Health Parity Implementation. 2024.
13. National Conference of State Legislatures. State Laws Mandating or Regulating Mental Health Benefits. 2025.
14. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Saxenda, and Rybelsus are registered trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. All other trademarks are the property of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

Tax Disclaimer. This article provides general information about FSA and HSA reimbursement rules based on IRS publications and does not constitute tax advice. Consult a qualified tax professional regarding your specific situation. FormBlends is not a tax advisor and does not provide tax, legal, or accounting advice.